FDC Regulatory Approval

Legal & Regulatory

FDC Legal & Regulatory

FDC Ltd has received a favorable income tax refund order of Rs. 20.71 Crore for AY 2013-14. The jurisdictional Assessing Officer issued the refund following a successful appeal.

Value

₹20.71 Cr

Legal & Regulatory

FDC Legal & Regulatory

FDC Limited received a favorable income tax refund order for Assessment Year 2016-17. The Assistant Commissioner of Income Tax determined an aggregate refund of Rs. 14.20 Crore.

Value

₹14.20 Cr

From

Assistant Commissioner of Income Tax, Circle – 1(3)(1), Mumbai

Legal & Regulatory

FDC Legal & Regulatory

FDC received tax orders giving an aggregate refund of Rs.37.22 Crore for AY 2014-15 and AY 2012-13. The refund follows favourable CIT(A) orders on the company's appeals.

Value

₹37.22 Cr

Results Update

FDC Results Update

FDC Limited reports Q2 FY27 revenue of Rs. 572 crore, up 21%, and EBITDA of Rs. 64 crore. Domestic formulations grew 22.6% and international formulations rose 28.5%.

Financial Results

FDC Q2 FY27 Results: Net Profit ₹49.1 Cr, Up 72.9% YoY

FDC Ltd reported revenue from operations of ₹572.1 Cr (+21.0% YoY) and net profit of ₹49.1 Cr (+72.9% YoY) for Q2 FY27.

Key figure

Net profit ₹49.1 Cr · +72.9% YoY

Capital Structure Change

FDC Capital Structure Change

FDC's board approved a buyback of up to ₹120 Crore at ₹500 per share via tender offer. The record date is November 13, 2026.

Value

₹120.0 Cr

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.